Sameh Fahim-Gadallah, MD
Cardiology · Lancaster, CANPI 1205897535
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Edwards Lifesciences at 33.4% of the total. 2025 is the largest year on record at $7,074, 8.4 times the $840 reported in 2019. Among cardiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 376 payments — averaging $40.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$5K
- Abbott$3K
- Medtronic$1K
- Amgen$823
- Merck$791
- AstraZeneca$687
- plus $4K from 32 others
What the payments were for
- Travel & lodging$6,17841%
- Food & beverage$8,84159%
- Education$540%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 31 | $5,027 |
| Abbott | 33 | $2,686 |
| Medtronic(2 entities) | 21 | $1,318 |
| Amgen | 33 | $823 |
| Merck | 32 | $791 |
| AstraZeneca | 43 | $687 |
| Pfizer | 30 | $460 |
| Boston Scientific | 17 | $442 |
| Boehringer Ingelheim | 18 | $403 |
| Abiomed | 13 | $360 |
| Irhythm Technologies, Inc. | 32 | $299 |
| Philips North America LLC | 3 | $161 |
| E.r. Squibb & Sons, L.L.C. | 7 | $140 |
| Lexicon Pharmaceuticals, Inc. | 5 | $132 |
| Alnylam Pharmaceuticals Inc. | 6 | $129 |
| Biosense Webster, Inc. | 2 | $129 |
| Johnson & Johnson | 5 | $116 |
| Novartis | 7 | $111 |
| Esperion Therapeutics, Inc. | 5 | $110 |
| Chiesi USA, Inc. | 4 | $101 |
| Regeneron Healthcare Solutions, Inc. | 5 | $77 |
| Shockwave Medical, Inc | 1 | $76 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $69 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $55 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Impulse Dynamics (USA) Inc. | 1 | $43 |
| Lilly USA, LLC | 2 | $38 |
| Cathworks, Inc. | 2 | $38 |
| Scpharmaceuticals Inc. | 2 | $35 |
| United Therapeutics Corporation | 1 | $33 |
| Cardiva Medical, Inc. | 1 | $24 |
| Bayer | 1 | $22 |
| Teleflex LLC | 1 | $18 |
| Biotronik Inc. | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| EKOS Corporation | 1 | $17 |
| Heartflow, Inc. | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRICLIP$1,478
- SAPIEN 3 Ultra RESILIA$1,305
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,183
- MitraClip$543
- EVERA MRI XT DR SURESCAN$509
- WATCHMAN Access System$170
- EVOQUE$153
- Impella$125
- SelectSecure$107
How this compares
$15,073 in reported general payments places this provider in the 90th percentile of 156 cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 148 | $205,293 |
| EntrestoSacubitril/Valsartan | 62 | $71,168 |
| JardianceEmpagliflozin | 47 | $68,906 |
| OzempicSemaglutide | 61 | $63,214 |
| FarxigaDapagliflozin Propanediol | 45 | $56,788 |
| XareltoRivaroxaban | 37 | $49,213 |
| Repatha SureclickEvolocumab | 30 | $22,755 |
| MounjaroTirzepatide | 13 | $16,551 |
| Praluent PenAlirocumab | 22 | $10,599 |
| Rosuvastatin Calcium | 354 | $6,215 |
| Amiodarone Hcl | 75 | $5,861 |
| Metoprolol Succinate | 253 | $4,139 |
| Valsartan | 118 | $2,991 |
| ClopidogrelClopidogrel Bisulfate | 247 | $2,894 |
| Atorvastatin Calcium | 276 | $2,598 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $460 | $205,293148 claims |
| NovartisEntresto | $111 | $71,16862 claims |
| Boehringer IngelheimJardiance | $403 | $68,90647 claims |
| Novo NordiskOzempic | $18 | $63,21461 claims |
| AstraZenecaFarxiga | $687 | $56,78845 claims |
| Johnson & JohnsonXarelto | $116 | $49,21337 claims |
| Lilly USA, LLCMounjaro | $38 | $16,55113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 156 cardiology providers in California.
Other cardiology in Lancaster
- Pramod KadambiLancaster$7K
- Shun SunderLancaster$609
- Norman LeporBeverly Hills$1.9M
- Sanjay KaulLos Angeles$1.1M
- Ramtin AgahMountain View$361K
- Jamshid MaddahiLos Angeles$59K
- Bipin JoshiFresno$51K
- Anil ShahSanta Ana$49K
- Thomas KimSanta Ana$47K
- Hooman MadyoonLos Angeles$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.